melhor horario fortune rabbit
ALHAMBRA, Calif. , Dec. 19, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the J.P. Morgan 2025 Healthcare Conference, being held in San Francisco , on Tuesday, January 14, 2024 , including a presentation at 10:30am PT from President and CEO of Astrana Health, Brandon Sim . The webcast link and related presentation materials will be available in the "IR Calendar" section of the Company's website: https://ir.astranahealth.com/news-events/ir-calendar . About Astrana Health, Inc. Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner. Headquartered in Alhambra, California , Astrana serves over 12,000 providers and over 1.1 million Americans in value-based care arrangements. Its subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care. For more information, please visit www.astranahealth.com . FOR MORE INFORMATION, PLEASE CONTACT: Investor Relations (626) 943-6491 Asher Dewhurst , ICR Healthcare investors@astranahealth.com View original content to download multimedia: https://www.prnewswire.com/news-releases/astrana-health-inc-to-participate-in-upcoming-investor-conference-302336639.html SOURCE Astrana Health, Inc.The Sydney business turning Fiji’s beach litter into power poles
Sanctuary Advisors LLC Lowers Stock Position in Global X U.S. Preferred ETF (NYSEARCA:PFFD)PHILADELPHIA , Dec. 19, 2024 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its fourth quarter 2024 earnings on Tuesday, February 4, 2025 , after the stock market close via PR Newswire and the company's website https://investors.fmc.com . The company will host a webcast conference call on Tuesday, February 4, 2025 , at 5:00 p.m. ET that is open to the public via internet broadcast and telephone. At this time, management will provide commentary on the results from the fourth quarter and full year 2024, guidance for the first quarter and full year 2025, as well as an update on the three-year outlook and the company's strategy. The call time has been extended to 90 minutes from the usual 60 minutes to accommodate the number of topics and Q&A adequately. Conference Call Details: Internet broadcast: https://investors.fmc.com United States (Local): +1 404 975 4839 United States ( Toll-Free ): +1 833 470 1428 Global Dial-In Numbers: Global Dial-in Number Access Code: 338624 Pre-Registration Link: https://www.netroadshow.com/events/login?show=2f7e0221&confId=75596 A replay of the call will be available via the internet and telephone from 6:30 p.m. ET on February 4, 2025 , until February 24, 2025 . Internet replay: https://investors.fmc.com United States (Local): 1 929 458 6194 United States ( Toll-Free ): 1 866 813 9403 Access Code: 793208 About FMC FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. With approximately 5,800 employees at more than 100 sites worldwide, FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn ® . View original content to download multimedia: https://www.prnewswire.com/news-releases/fmc-corporation-announces-date-for-fourth-quarter-2024-earnings-release-and-webcast-conference-call-302336288.html SOURCE FMC CorporationA bunch of maniacs managed to put the powertrain, motors and battery pack, of a Tesla Model S Plaid in a Cobra kit. The result is a scary fast, and light (for an EV), EV monster. We have seen many EV conversion kits using Tesla battery packs and motors, but a base Tesla vehicle generally has plenty of power and energy to power EV conversion kits. Don Swadley, who we know from , had different ambitions. He aimed to put an entire Tesla Model S Plaid powertrain inside a smaller, and lighter sports car. He a Cobra kit car. That’s a ~100 kWh battery pack and three electric motors putting 760 kW (1,060 hp) of power inside a Cobra. I honestly couldn’t believe you could fit that in there, but I talked to the guys at , who made the controller for the EV conversion’s powertain, and they confirmed it. Swadley let Revolt Systems test out the vehicle and they came out impressed. As he says, it’s probably “too much power”: It weighs about 3,300 lbs. That’s about 1,450 lbs lighter than a regular Model S Plaid, which is about 4,750 lbs. They had to make the chassis longer to fit the entire powertrain, but this thing works... probably too well. It’s basically the third iteration of the vehicle, but it’s the first one with a Plaid powertrain. Swadley claims that it’s the first swap EV with a Plaid powertrain and I can’t prove him wrong right now. What do you guys think about this electric machine? Let us know in the comment section below. and subscribe to the . Tesla is a transportation and energy company. It... Fred is the Editor in Chief and Main Writer at Electrek. You can send tips on Twitter (DMs open) or via email: fred@9to5mac.com Through Zalkon.com, you can check out Fred’s portfolio and get monthly green stock investment ideas. Get interesting investment ideas by Fred Lambert ChargePoint Home WiFi Enabled Electric Vehicle (EV) Charger
Booz Allen Appoints Debra L. Dial to Board of Directors
AP News Summary at 3:19 p.m. EST
Tottenham joins list of top Premier League teams to lose at Bournemouth after Huijsen winnerNicholas Fuller had trouble finding his footing after receiving a degree in corrosive technology. “I moved down to Houston for a job, and it was pipeline-related work,” he said. “Through working that, I realized that wasn’t my preferred kind of thing to do. But through that job, I realized I like electrical stuff, mainly electrical troubleshooting.” Fuller enrolled in Texas State Technical College’s industrial systems program after returning to Longview. Fuller estimated that he worked in electrical troubleshooting for almost six years before enrolling at the Marshall campus. He said the knowledge that TSTC has provided him with is something he wished he had previously had in the workforce. “Say I’m given an electrical component,” Fuller said. “I know it’s bad and it needs replacing, but why is that? You’re trained to remember to do this, but it still doesn’t necessarily mean you know why. Education-wise, if I could go back to a few years ago but already have what I’ve learned, it would make so much more sense. It’s connecting some dots.” Fuller said he is a fan of the labs and hands-on training provided by the industrial systems program. He plans to receive his associate of applied science degree with an electrical specialization in December 2025. “It’s nice to know that, one year from now, I’ll have my degree,” Fuller said. John Fondren, an industrial systems instructor at TSTC’s Marshall campus, admires Fuller’s dedication to the program. “Mr. Fuller is one of the most focused individuals I have this year,” he said. “I believe it is due to his past that he knows how important this program is because he has been out there and seen how things work.” According to onetonline.org , electromechanical and mechatronics technologists and technicians earn an average of $59,940 per year in Texas, where the number of such jobs was projected to increase 12% from 2020 to 2030. industrial systems is available at TSTC’s Abilene, East Williamson County, Fort Bend County, Marshall, New Braunfels, North Texas and Waco campuses. The program offers several associate degrees and certificates of completion.
Geoffrey Hinton says he doesn’t regret the work he did that laid the foundations of artificial intelligence, but wishes he thought of safety sooner. The British-Canadian computer scientist often called the godfather of AI said over the weekend that he doesn’t have any guilty regret, which he said is when someone has done something when they know they shouldn’t have at the time. “In the same circumstances, I would do the same again,” he said of his research, which dates back to the 1980s and has formed the underpinnings of AI. “However, I think it might have been unfortunate in that we're going to get superintelligence faster than I thought, and I wish I'd thought about safety earlier.” Superintelligence surpasses the abilities of even the smartest humans. Hinton thinks it could arrive in the next five to 20 years and humanity may have to “worry seriously about how we stay in control.” Hinton made his prediction during a press conference in Stockholm, where he is due to a receive the Nobel Prize in physics on Tuesday. Hinton, a University of Toronto professor emeritus, and co-laureate John Hopfield, a Princeton University professor, are being given the prize because they developed some of the foundations of machine learning, a computer science that helps AI mimic how humans learn. Hinton kicked off his Nobel week on Saturday with the press conference, where he appeared with laureates in chemistry and economics and was asked about AI safety and regulation. Hinton left a job at Google last year to speak more freely about the technology's dangers, which he has said could include job losses, bias and discrimination, echo chambers, fake news, battle robots and even the end of humanity. On Saturday, he said he considers lethal autonomous weapons to be a short-term danger. "There isn't going to be any regulation there," he said, pointing out that European regulations have a specific clause exempting military use of AI from restrictions. "Governments are unwilling to regulate themselves, when it comes to lethal autonomous weapon, and there is an arms race going on between all the major arms suppliers like the United States, China, Russia, Britain, Israel and possibly even Sweden, though I don't know." A day later, Hinton put his concerns about AI aside to deliver a lecture with Hopfield explaining the research that earned them their Nobel. "Today I am going to do something very foolish." Hinton said in introducing his portion of the pair's hour-long speech. "I am going to try and describe a complicated technical idea for a general audience without using any equations." The audience chuckled. The talk began with Hopfield describing a network he invented that could store and reconstruct images in data. It led Hinton to later create the Boltzmann machine, which learns from examples, rather than instructions, and when trained, can recognize familiar characteristics in information, even if it has not seen that data before. Hinton said students in his lab and others run by fellow AI pioneers Yoshua Bengio and Yann LeCun were using Boltzmann machines to pre-train neural networks — machine learning models that make decisions in a manner similar to the human brain — between 2006 and 2011. By 2009, two of Hinton's students had showed the technique "worked a little bit better than the best existing techniques for recognizing fragments of phonemes in speech and that then changed the speech recognition community," Hinton said. Phonemes are small units of sound that can change the meaning of a word. Google later began working on technology based on Hinton's discoveries and "suddenly the speech recognition on the Android got a lot better." Even though the kind of Boltzmann machines Hinton was working with back then are no longer used in the same ways as he used them, he said "they allowed us to make the transition from thinking that deep neural networks would never work to seeing that deep neural networks actually could be made to work." Nobel Week will continue Monday with a discussion about the future of health before an awards ceremony and banquet is held Tuesday. Hinton has said he will donate a portion of the prize money — equivalent to about C$1.45 million — he and Hopfield will be given to Water First, which is working to boost Indigenous access to water, and a charity supporting neurodiverse young adults. He is also reportedly due to donate an early Boltzmann chip to the Nobel Prize Museum. The Nobel is not the only prize Hinton scooped up this month. On Friday, he, Bengio, LeCun, Chinese-American computer scientist Fei-Fei Li and Nvidia founder Jensen Huang, were awarded the Vin Future Prize, a US$3 million prize for science breakthroughs in a ceremony in Vietnam. Hinton, Bengio and LeCun previously won the A.M. Turing Award, known as the Nobel Prize of computing, together in 2018. This report by The Canadian Press was first published on Dec. 8, 2024. Tara Deschamps, The Canadian PressNIKE, Inc. Reports Fiscal 2025 Second Quarter Results
A new contender in the cryptocurrency world is generating significant buzz among early investors. This presale standout is believed to have the potential to surpass Cardano by 2025. With its innovative approach and ambitious roadmap, it is capturing attention and stirring intrigue. Could this be the next major player to reshape the crypto landscape? CYBRO, an AI-powered multichain earn marketplace, is about to hit a major milestone with its Token Generation Event (TGE). After a lightning-fast presale that raised an impressive $7 million and drew in nearly 20,000 investors, CYBRO is now gearing up for its listing on Gate.io and other major exchanges — and it’s happening on December 14th. During the presale, $CYBRO’s price surged 450% from $0.01 to $0.055 in its final stage. Now, with the token set to list at $0.06 on major exchanges, demand is through the roof. Many are predicting a 100x price surge once it hits the open market, thanks to the strong momentum and solid fundamentals backing the project. Join CYBRO Before the Listing Frenzy Drives Prices to the Moon What’s behind the hype? CYBRO combines cutting-edge AI with a user-friendly platform, offering tools like staking, farming, and lending that make DeFi investing accessible to everyone — from cautious newcomers to bold risk-takers. During its short presale, CYBRO has already gone a long way in achieving crucial milestones: CYBRO App Launched: Users can now explore around 30 vaults offering competitive annual percentage yields (APY) to match their investment strategies perfectly First One-Click Strategy Introduced: The Blast Index, available in the Vaults list and on the One-Click page, simplifies investing by integrating with lending protocols Rapid Development Progress: CYBRO’s platform has laid the groundwork for seamless DeFi experiences, setting the stage for future growth and innovation. And there’s more to come. CYBRO’s roadmap through 2025 promises features like leverage farming, lending aggregators, and even smarter AI tools, cementing its place as a game-changer in decentralized finance. With the listing just around the corner, $CYBRO is about to make its mark on major exchanges with all the momentum it’s built so far, this token looks ready to take off. Cardano is a blockchain platform built for smart contracts. It enables developers to create decentralized finance apps, crypto tokens, and games. Its native cryptocurrency, ADA, allows users to store value, make payments, and stake on the network. Cardano uses the Ouroboros proof-of-stake mechanism, which is more energy-efficient than the proof-of-work model. The blockchain is divided into two layers: the Cardano Settlement Layer for transactions and the Cardano Computing Layer for smart contracts This design enhances its ability to process transactions, potentially handling up to 1 million transactions per second. Cardano’s native tokens offer secure, low-fee interactions with smart contracts, improving blockchain efficiency and scalability. With the bull run of 2024 already in motion, established cryptocurrencies like ADA are showing less short-term potential. In contrast, CYBRO is emerging as a technologically advanced DeFi platform that offers investors unparalleled opportunities to maximize earnings. Utilizing AI-powered yield aggregation on the Blast blockchain, CYBRO provides lucrative staking rewards, exclusive airdrops, and cashback on purchases. Users benefit from seamless deposits and withdrawals, enhancing the overall experience. By emphasizing transparency, compliance, and quality, CYBRO stands out as a promising project attracting strong interest from crypto whales and influencers. This positions CYBRO as a compelling option for investors seeking significant returns, potentially surpassing more established coins by 2025. Read also: How this $0.06 AI token could outpace Ripple and Cardano by 2025OTTAWA - Parents of children who died because of online sexual extortion are urging MPs to act on online harms legislation. The bill and other legislation have been blocked from moving forward for months due to a parliamentary privilege debate raging between the Liberals and Conservatives. Justice Minister Arif Virani split the bill into two parts this week heeding calls from critics to separate the more controversial hate speech provisions from the child exploitation components. But the bill still can’t move forward until the privilege filibuster is over. Barbie Lavers, whose teenage son died by suicide after being extorted online over intimate images, told House of Commons committee today that she supports the act and asked politicians to come to a temporary alliance and stop using children as political pawns to show “one party is more correct than the other.” Carole Todd, whose daughter Amanda died by suicide due to online sextortion, told MPs it is hurtful to watch political arguments after waiting 12 years for legislation. This report by The Canadian Press was first published Dec. 5, 2024.
Franklin Resources Inc. Grows Stock Holdings in Clear Secure, Inc. (NYSE:YOU)
B.C. premier says feds and premiers have right-left strategy to tackle Trump tariffs'Placed Sonia Gandhi as super PM, insulted him': Nadda rebukes Rahul Gandhi's remarks on Manmohan Singh's last rites
US President Joe Biden on Sunday said deposed Syrian leader Bashar al-Assad should be "held accountable" but called the nation's political upheaval a "historic opportunity" for Syrians to rebuild their country. In the first full US reaction to Assad's overthrow by an Islamist-led coalition of rebel factions, Biden also warned that Washington will "remain vigilant" against the emergence of terrorist groups, announcing that US forces had just conducted fresh strikes against militants from the Islamic State organization. "The fall of the regime is a fundamental act of justice," Biden said, speaking from the White House. "It's a moment of historic opportunity for the long-suffering people of Syria." Asked by reporters what should happen to the deposed president, who reportedly has fled to Moscow, Biden said that "Assad should be held accountable." Biden -- set to step down in January and make way for Republican Donald Trump's return to power -- said Washington will assist Syrians in rebuilding. "We will engage with all Syrian groups, including within the process led by the United Nations, to establish a transition away from the Assad regime toward independent, sovereign" Syria "with a new constitution," he said. However, Biden cautioned that hardline Islamist groups within the victorious rebel alliance will be under scrutiny. "Some of the rebel groups that took down Assad have their own grim record of terrorism and human right abuses," Biden said. The United States had "taken note" of recent statements by rebels suggesting they had since moderated, he said, but cautioned: "We will assess not just their words, but their actions." Biden said Washington is "clear eyed" that the Islamic State extremist group, often known as ISIS, "will try to take advantage of any vacuum to reestablish" itself in Syria. "We will not let that happen," he said, adding that on Sunday alone, US forces had conducted strikes against ISIS inside Syria. The US military said the strikes were conducted by warplanes against Islamic State operatives and camps. Strikes were carried out against "over 75 targets using multiple US Air Force assets, including B-52s, F-15s, and A-10s," the US Central Command said on social media. Earlier, Biden met with his national security team at the White House to discuss the crisis. Assad's reported departure comes less than two weeks after the Islamist Hayat Tahrir al-Sham (HTS) group challenged more than five decades of Assad family rule with a lightning rebel offensive that broke long-frozen frontlines in Syria's civil war. They announced Sunday they had taken the capital Damascus and that Assad had fled, prompting celebrations nationwide and a ransacking of Assad's luxurious home. A Kremlin source told Russian news agencies that the deposed leader was now in Moscow, along with his family. The US military has around 900 troops in Syria and 2,500 in Iraq as part of the international coalition established in 2014 to help combat the Islamic State jihadist group. It has regularly struck targets in the country including those linked to Iranian-backed militias. Tehran was a major backer of Assad's government. Biden also confirmed US authorities believe the American journalist Austin Tice, who was abducted in Syria in 2012, still lives. "We believe he's alive," Biden said, but the US has yet "to identify where he is." bur-sms/mlmwashington (ap) – Nearly 100 former senior U.S. diplomats and intelligence and national security officials have urged Senate leaders to schedule closed-door hearings to allow for a full review of the government’s files on former Rep. Tulsi Gabbard , Donald Trump’s pick to be national intelligence director. The former officials, who served in both Democratic and Republican administrations, said they were “alarmed” by the choice of Gabbard to oversee all 18 U.S. intelligence agencies. They said her past actions “call into question her ability to deliver unbiased intelligence briefings to the President, Congress, and to the entire national security apparatus.” A spokesperson for Gabbard on the Trump transition team on Thursday denounced the appeal as an “unfounded” and “partisan” attack. Avril Haines, the current director of national intelligence, when asked Thursday whether intelligence sharing with allies could be in jeopardy under the next administration, cited the importance of those relationships and noted the strong bipartisan support for them in Congress. The question, at a Council on Foreign Relations talk, focused on the especially close intelligence sharing among the Five Eyes — the U.S., Britain, Canada, Australia and New Zealand. It did not mention Gabbard by name. “It is hard for me to believe that anybody coming in wouldn’t want to maintain those relationships,” Haines said. “So I wouldn’t think of them as being in significant risk,” she added. “I certainly hope that will continue.” Among those who signed the letter to Senate leaders were former Deputy Secretary of State Wendy Sherman, former NATO Deputy Secretary General Rose Gottemoeller, former national security adviser Anthony Lake, and numerous retired ambassadors and high-ranking military officers. They wrote to current Democratic Senate Majority Leader Chuck Schumer and incoming Republican Majority Leader John Thune on Wednesday to urge the closed briefings as part of the Senate’s review of Trump’s top appointments. They requested that Senate committees “consider in closed sessions all information available to the U.S. government when considering Ms. Gabbard’s qualifications to manage our country’s intelligence agencies, and more importantly, the protection of our intelligence sources and methods.” The letter singles out Gabbard’s 2017 meetings in Syria with President Bashar Assad, who is supported by Russian, Iranian and Iranian-allied forces in a now 13-year war against Syrian opposition forces seeking his overthrow. The U.S., which cut relations with Assad’s government and imposed sanctions over his conduct of the war, maintains about 900 troops in opposition-controlled northeast Syria, saying they are needed to block a resurgence of extremist groups. Gabbard, a Democratic member of Congress from Hawaii at the time of her Syria trip, drew heavy criticism for her meetings with a U.S. adversary and brutal leader. As the letter notes, her statements on the wars in the Middle East and Ukraine have aligned with Russian talking points , diverging from U.S. positions and policy. Gabbard throughout her political career has urged the U.S. to limit military engagement abroad other than combatting Islamic extremist groups. She has defended the Syria trip by saying it is necessary to engage with U.S. enemies. In postings on social media earlier this year she confirmed that the U.S. had for a time placed her “on a secret terror watch list” as a “potential domestic terror threat.” She blamed political retaliation. Neither she nor U.S. authorities have publicly detailed the circumstances involved. Alexa Henning, a spokesperson for Gabbard with the Trump team, called the letter sent to the Senate leaders “a perfect example” of why Trump chose Gabbard for this position. “These unfounded attacks are from the same geniuses who have blood on their hands from decades of faulty ‘intelligence,’” and use classified government information as a “partisan weapon to smear and imply things about their political enemy,” Henning said. A spokesperson for Thune did not immediately respond to questions about the request. —- Associated Press writer Didi Tang contributed.Leak Suggests Switch 2 Will Finally Fix The Original’s Most Notorious Problem
Geode Capital Management LLC lifted its holdings in AMERISAFE, Inc. ( NASDAQ:AMSF – Free Report ) by 1.4% in the third quarter, HoldingsChannel reports. The firm owned 453,539 shares of the insurance provider’s stock after purchasing an additional 6,166 shares during the quarter. Geode Capital Management LLC’s holdings in AMERISAFE were worth $21,924,000 at the end of the most recent reporting period. Other institutional investors and hedge funds have also recently modified their holdings of the company. Public Employees Retirement Association of Colorado grew its holdings in shares of AMERISAFE by 5.1% in the second quarter. Public Employees Retirement Association of Colorado now owns 315,409 shares of the insurance provider’s stock valued at $13,843,000 after purchasing an additional 15,196 shares in the last quarter. State Street Corp grew its holdings in shares of AMERISAFE by 8.5% in the third quarter. State Street Corp now owns 811,561 shares of the insurance provider’s stock valued at $39,223,000 after purchasing an additional 63,638 shares in the last quarter. Jane Street Group LLC grew its holdings in shares of AMERISAFE by 70.6% in the third quarter. Jane Street Group LLC now owns 41,299 shares of the insurance provider’s stock valued at $1,996,000 after purchasing an additional 17,084 shares in the last quarter. Intech Investment Management LLC bought a new stake in AMERISAFE in the second quarter worth $591,000. Finally, BNP Paribas Financial Markets boosted its stake in AMERISAFE by 6.9% during the third quarter. BNP Paribas Financial Markets now owns 5,882 shares of the insurance provider’s stock worth $284,000 after buying an additional 381 shares during the period. 97.41% of the stock is owned by hedge funds and other institutional investors. Wall Street Analyst Weigh In A number of research analysts have weighed in on AMSF shares. Truist Financial boosted their price objective on shares of AMERISAFE from $48.00 to $54.00 and gave the company a “hold” rating in a research report on Friday, October 25th. JMP Securities reissued a “market outperform” rating and issued a $65.00 price objective on shares of AMERISAFE in a research note on Tuesday, October 15th. AMERISAFE Price Performance Shares of NASDAQ AMSF opened at $51.63 on Friday. The company has a market cap of $983.55 million, a P/E ratio of 16.13 and a beta of 0.33. AMERISAFE, Inc. has a 1 year low of $41.97 and a 1 year high of $60.24. The firm has a 50-day simple moving average of $55.60 and a two-hundred day simple moving average of $50.08. AMERISAFE ( NASDAQ:AMSF – Get Free Report ) last announced its quarterly earnings data on Wednesday, October 23rd. The insurance provider reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.02. The business had revenue of $78.70 million during the quarter, compared to the consensus estimate of $75.38 million. AMERISAFE had a net margin of 19.49% and a return on equity of 16.50%. During the same quarter last year, the firm earned $0.61 earnings per share. As a group, equities research analysts expect that AMERISAFE, Inc. will post 2.45 EPS for the current year. AMERISAFE Increases Dividend The company also recently disclosed a quarterly dividend, which was paid on Friday, December 13th. Shareholders of record on Friday, December 6th were paid a $3.37 dividend. The ex-dividend date was Friday, December 6th. This represents a $13.48 annualized dividend and a yield of 26.11%. This is an increase from AMERISAFE’s previous quarterly dividend of $0.37. AMERISAFE’s dividend payout ratio (DPR) is presently 46.25%. AMERISAFE Company Profile ( Free Report ) AMERISAFE, Inc, an insurance holding company, underwrites workers’ compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime. Further Reading Want to see what other hedge funds are holding AMSF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMERISAFE, Inc. ( NASDAQ:AMSF – Free Report ). Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter .BETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers. This acquisition expands OraSure's innovation pipeline with the addition of Sherlock's molecular diagnostics platform, which is able to provide rapid results with strong sensitivity and specificity in a disposable format that is well-suited for over-the-counter usage. Sherlock's first molecular self-test is for Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (NG) which will expand OraSure's portfolio of rapid diagnostics for sexually transmitted infections (STIs), subject to regulatory approvals. Test results are expected to be provided in under 30 minutes by analyzing DNA and RNA from self-collected swabs using isothermal amplification. In addition, Sherlock has been developing a pipeline of other molecular tests, along with several next-generation technology platforms, including Ambient Temperature Amplification and CRISPR-based technologies that have the potential to further reduce costs and improve performance of its platforms. Sherlock's CT/NG self-test is in clinical studies and is expected to be submitted to the FDA by the end of 2025 for review. Subject to regulatory approvals, revenue from Sherlock's CT/NG test is expected to contribute to OTI's growth beginning in 2026, benefitting from OraSure's existing infrastructure, commercial capabilities, and strong customer relationships. OTI estimates that testing for CT/NG represents a total addressable market of more than $1.5 billion. The vast majority of CT/NG tests in the U.S. are processed in a centralized lab, and the introduction of an affordable, rapid self-test has the potential to drive significant incremental market expansion. Additionally, public health channels play a key role in STI screening, which is an area where OraSure has a strong presence. "The acquisition of Sherlock represents the next step in OTI's innovation strategy,” said Carrie Eglinton Manner, President and CEO of OraSure. "Sherlock brings valuable capabilities with an advanced molecular platform that aims to deliver lab-like accuracy in a format that expands access to diagnostic insights through convenient, effortless tests. We are excited to welcome Sherlock's talented team to OTI and believe that Sherlock's unique capabilities will contribute significantly to the expansion of our pipeline of diagnostic tests in infectious disease, sexual health, and beyond.” Conference Call Information OraSure will host a conference call to discuss the acquisition of Sherlock Biosciences at 5:00 p.m. ET on Thursday, Dec. 19, 2024. A webcast of the conference call will be available on the investor relations page of OraSure's website at https://orasure.gcs-web.com/events-and-presentations . Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure's website shortly after the call has ended and will be available for approximately 90 days. To participate in the live conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email. https://register.vevent.com/register/BIb938f5bae2a442d9acdb83f4bdd9286d About OraSure Technologies, Inc. OraSure Technologies, Inc. ("OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiary, DNA Genotek Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure's portfolio of products is sold globally to clinical laboratories, hospitals, physician's offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com Forward Looking Statements This press release contains certain "forward-looking statements” within the meaning of the Federal securities laws, including with respect to products, product development and manufacturing activities, the Company's acquisition of Sherlock, revenue growth, cash flow, increasing margins and other matters. Words such as "expects,” "estimates,” "forecasts,” "intends,” "plans,” "projects,” "could,” "may,” "should,” "will” or other similar words and expressions are intended to identify these forward-looking statements. Forward-looking statements are not guarantees of future performance or results. Known and unknown factors that could cause actual performance or results to be materially different from those expressed or implied in these statements include, but are not limited to: the Company's ability to integrate Sherlock's business and achieve the intended benefits of the acquisition on the timeline expected or at all; Sherlock's ability to seek and obtain regulatory approval for products in development; the Company's ability to satisfy customer demand; ability to reduce the Company's spending rate, capitalize on manufacturing efficiencies and drive profitable growth; ability to achieve the anticipated cost savings as a result of the Company's business restructuring, including from insourcing third party manufacturing and exiting microbiome services; ability to market and sell products, whether through the Company's internal, direct sales force or third parties; impact of significant customer concentration in the genomics business; failure of distributors or other customers to meet purchase forecasts, historic purchase levels or minimum purchase requirements for the Company's products; ability to manufacture or have manufactured products in accordance with applicable specifications, performance standards and quality requirements; ability to obtain, and timing and cost of obtaining, necessary regulatory approvals for new products or new indications or applications for existing products; ability to comply with applicable regulatory requirements; ability to effectively resolve warning letters, audit observations and other findings or comments from the FDA or other regulators; the impact of the novel coronavirus ("COVID-19”) pandemic on the Company's business, supply chain, labor force, ability to successfully develop new products, validate the expanded use of existing collector products, receive necessary regulatory approvals and authorizations and commercialize such products for COVID-19 testing, and demand for the Company's COVID-19 testing products; changes in relationships, including disputes or disagreements, with strategic partners or other parties and reliance on strategic partners for the performance of critical activities under collaborative arrangements; ability to meet increased demand for the Company's products; impact of replacing distributors; inventory levels at distributors and other customers; ability of the Company to achieve its financial and strategic objectives and continue to increase its revenues, including the ability to expand international sales and the ability to continue to reduce costs; impact of competitors, competing products and technology changes; reduction or deferral of public funding available to customers; competition from new or better technology or lower cost products; ability to develop, commercialize and market new products; market acceptance of oral fluid or urine testing, collection or other products; market acceptance and uptake of microbiome informatics, microbial genetics technology and related analytics services; changes in market acceptance of products based on product performance or other factors, including changes in testing guidelines, algorithms or other recommendations by the Centers for Disease Control and Prevention or other agencies; ability to fund research and development and other products and operations; ability to obtain and maintain new or existing product distribution channels; reliance on sole supply sources for critical products and components; availability of related products produced by third parties or products required for use of the Company's products; impact of contracting with the U.S. government; impact of negative economic conditions; ability to maintain sustained profitability; ability to utilize net operating loss carry forwards or other deferred tax assets; volatility of the Company's stock price; uncertainty relating to patent protection and potential patent infringement claims; uncertainty and costs of litigation relating to patents and other intellectual property; availability of licenses to patents or other technology; ability to enter into international manufacturing agreements; obstacles to international marketing and manufacturing of products; ability to sell products internationally, including the impact of changes in international funding sources and testing algorithms; adverse movements in foreign currency exchange rates; loss or impairment of sources of capital; ability to attract and retain qualified personnel; exposure to product liability and other types of litigation; changes in international, federal or state laws and regulations; customer consolidations and inventory practices; equipment failures and ability to obtain needed raw materials and components; cybersecurity breaches or other attacks involving the Company's systems or those of the Company's third-party contractors and IT service providers; the impact of terrorist attacks, civil unrest, hostilities and war; and general political, business and economic conditions, including inflationary pressures and banking stability. These and other factors that could affect the Company's results are discussed more fully in the Company's filings with the Securities and Exchange Commission (the "SEC”), including the Company's registration statements, Annual Report on Form 10-K for the year ended December 31, 2023, Quarterly Reports on Form 10-Q, and other filings with the SEC. Although forward-looking statements help to provide information about future prospects, readers should keep in mind that forward-looking statements may not be reliable. Readers are cautioned not to place undue reliance on the forward-looking statements. The forward-looking statements are made as of the date of this press release and the Company undertakes no duty to update these statements.
AP News Summary at 9:52 a.m. EST
- Previous: melhor hora para jogar fortune rabbit
- Next: